Feasibility of a visual prosthesis for the blind based on intracortical microstimulation of the visual cortex.
E M Schmidt, M J Bak, F T Hambrecht...
https://pubmed.ncbi.nlm.nih.gov/8800945/Actively Recruiting
Led by Illinois Institute of Technology · Updated on 2026-06-03
5
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the feasibility of producing artificial vision in people who are blind by using a device called the Intracortical Visual Prosthesis ICVP. This study aims to test the safety of the ICVP system and evaluate whether electrical stimulation of the brains visual processing areas can create visual percepts. The study involves participants with no light perception or very limited vision who have been blind for at least one year and have a history of normal or near-normal vision in early life. The intervention involves implanting wireless floating microelectrode arrays WFMAs into the visual cortex on one side of the brain. These devices deliver wirelessly transmitted electrical stimulation intended to induce artificial vision. Each participant will have multiple WFMA devices implanted. After surgical recovery, participants will undergo weekly testing for one to three years to assess the ability of electrical stimulation to generate visual percepts and evaluate the devices safety and efficacy. Participants will attend regular testing sessions to measure visual perception responses to stimulation and monitor safety outcomes. Researchers will perform assessments from two weeks after surgery through the entire device use period, up to three years. The primary outcome is the safety of the WFMA-based cortical interface, while secondary measures evaluate its effectiveness at producing visual percepts. The study includes video and audio recordings, cognitive and spatial functioning tests, and MRI scans. Participant involvement may last up to three years, with ongoing monitoring throughout the study.
CONDITIONS
A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
R
Recruitment Director
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Illinois Institute of Technology
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | WFMA Cortical Visual Prosthesis | Standard Visual Rehabilitation |
|---|---|---|
| What is it? | A wireless floating microelectrode array (WFMA) device implanted in the visual cortex. It sends electrical signals directly to the brain to generate visual sensations (phosphenes) in adults with total acquired blindness. | A programme of orientation and mobility training, daily living skills, and assistive aids to help people with complete acquired blindness function and travel independently. No implanted device is used. |
| Role in the trial | Tested as an investigational device to assess safety and the ability to generate useful visual percepts in people with no light perception. | Used as the standard approach outside the trial for individuals with irreversible blindness for whom vision-restoring interventions are not available. |
| Primary use | Intended to create artificial vision by stimulating the visual cortex of adults with complete blindness. | Intended to improve safe navigation, independence, and quality of life through non-visual strategies. Does not restore vision. |
| How is it performed or delivered? | The WFMA device is surgically implanted in the brain's visual cortex. After recovery, specific wireless stimulation patterns are delivered to evoke sensations of light. Device function is evaluated over a multi-year period. | Provided through in-person training by rehabilitation specialists, focusing on cane techniques, daily living skills, and accessible technology. No surgery or implanted device is involved. |
| Level of existing evidence | Early evidence from feasibility studies shows that intracortical stimulation can produce visual sensations in some patients, but long-term effectiveness and daily function impact remain unproven. | Broad evidence supports visual rehabilitation and training as beneficial for safe navigation, adaptation, and improved quality of life, but it does not restore vision. |
| Important limitations | The device is experimental, with unknown long-term safety and functional outcomes. Only a very small number of participants have received this implant. Surgery and device complications are possible. | Conventional rehabilitation does not restore visual sensation. Effectiveness depends on participant motivation, cognitive capacity, and access to specialized resources. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Recovery period following surgery
Participants undergo implantation of wireless floating microelectrode arrays (WFMAs) in the visual cortex and recover from surgery.
Approximately 1 to 2 post-operative visits
Duration - Up to 3 years
Participants receive electrical stimulation via the implanted WFMAs to test safety and feasibility of eliciting visual percepts.
Weekly visits for testing over 1 to 3 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Have more questions? Get in touch with our team for quick support
E M Schmidt, M J Bak, F T Hambrecht...
https://pubmed.ncbi.nlm.nih.gov/8800945/M Bak, J P Girvin, F T Hambrecht...
https://pubmed.ncbi.nlm.nih.gov/2377008/Katarina Stephan, Philip R Troyk, Gislin Dagnelie...
https://pubmed.ncbi.nlm.nih.gov/40421717/Illinois Institute of Technology
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor